Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Accord Healthcare Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (605)
Cancellation by sponsor (114)
Prescription medicine registration (44)
Australian public assessment report (AusPar) (3)

Date

2026 (37)
2025 (69)
2024 (32)
2023 (68)
2022 (85)
2021 (52)
2020 (48)
2019 (93)
2018 (64)
2017 (40)
2016 (70)
2015 (36)
2014 (33)
2013 (7)
2012 (16)
2011 (16)

Search

Sponsor content

766 result(s) found, displaying 91 to 100

ARX-MERCAPTOPURINE (Accord Healthcare Pty Ltd)

5 August 2025

Prescription medicine registration

Active ingredients: mercaptopurine monohydrate.
ARIPADOL (Accord Healthcare Pty Ltd)

2 July 2025

Prescription medicine registration

Active ingredients: aripiprazole.
Arsenic Trioxide Accord arsenic trioxide 10 mg/10 mL injection vial Cancelled under Section 30(1)(c) of the Act

30 June 2025

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
DOCETAXEL ASTRON 80 mg/4 mL docetaxel concentrated injection 80 mg/4 mL glass vial Cancelled under Section 30(1)(c) of the Act

30 June 2025

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
DOCETAXEL ASTRON 20 mg/1 mL docetaxel concentrated injection 20 mg/1 mL glass vial Cancelled under Section 30(1)(c) of the Act

30 June 2025

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
DOCETAXEL ASTRON 160 mg/8 mL docetaxel concentrated injection 160 mg/8 mL glass vial Cancelled under Section 30(1)(c) of the Act

30 June 2025

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
PACLICCORD paclitaxel 30 mg/5 mL concentrated injection vial Cancelled under Section 30(1)(c) of the Act

30 June 2025

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
PACLICCORD paclitaxel 300 mg/50 mL concentrated injection vial Cancelled under Section 30(1)(c) of the Act

30 June 2025

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
PACLICCORD paclitaxel 100 mg/16.7 mL concentrated injection vial Cancelled under Section 30(1)(c) of the Act

30 June 2025

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
LEVOTHOX levothyroxine sodium 200 microgram tablet blister Cancelled under Section 30(1)(c) of the Act

13 June 2025

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd

Pages

First page
Previous page
…
Page 6
Page 7
Page 8
Page 9
Current page 10
Page 11
Page 12
Page 13
Page 14
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.